OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-09-30-accounts

- THE ELLISON CLIFFE CHARITABLE TRUST CHARITY REGISTRATION NO: 1062414

ACCOUNTS

FOR THE YEAR ENDED 30TH SEPTEMBER 2022

Page 1

THE ELLISON-CLIFFE CHARITABLE TRUST

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30[TH] SEPTEMBER 2022

LEGAL AND ADMINISTRATIVE DETAILS

The Ellison-Cliffe Charitable Trust was established by Deed in April 1997 to continue to establish a Travelling Fellowship and to apply income or capital from the Trust to such charitable institutions or charitable objects as the Trust think fit.

TRUSTEES

Dr Melita Irving (Chair) Mr Ian Balmer Mr Stephen Gilbert Professor Hugh Montgomery Dr John Scadding Mr Babulal Sethia Mr Ketish Pothalingam

OFFICE ADDRESS:

Royal Society of Medicine 1 Wimpole Street

London W1G 0AE

INDEPENDENT EXAMINER:

Kevin Lally FCA Knox Cropper LLP 65 Leadenhall Street London EC3A 2AD

BANKERS :

Bank of Scotland PO Box 1000 BX2 1LB

Page 2

THE ELLISON-CLIFFE CHARITABLE TRUST

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30[TH] SEPTEMBER 2022 (CONTINUED)

PUBLIC BENEFIT

The Trustees, confirm that they have complied with the duty set out in section 4 of the Charities Act 2011 to have due regard to the Charity Commission’s general guidance on public benefit when reviewing aims and objectives.

OBJECTIVES FOR THE YEAR

ACTIVITIES AND ACHIEVEMENTS DURING THE YEAR

The legacy has been received and has been invested with Cazenove as discretionary managers.

The travelling Fellowships were reestablished with 5 Travelling Fellowships with a total value of £45,000 being awarded.

The Trustee made a further donation of £250,000 to the Ellison Cliffe Lecture Fund held by the Royal Society of Medicine to sustain this prestigious event.

The Trustees held an away day where they considered the following:

  1. The Trust’s charitable objectives. These were reviewed and felt to still be appropriate. In reaching this decision the Trustees considered the following; What do the Object’s mean in plain English; are there any changes to the Trust’s Objects Trustees would like to propose; and The Ellison-Cliffe Annual Lecture, its organisation and funding.

  2. Public Benefit. Trustees felt that this requirement was being met.

  3. Trustees held a detailed discussion on the organisation and potential opportunities for the EllisonCliffe Travelling Fellowship reviewing the following questions: What is the purpose of the Travelling Fellowship; Opportunities to expand the reach and impact of the Travelling Fellowship; Accountability- demonstrating public benefit and impact and Application process – what for the future.

  4. A through review of the administration of the Trust

  5. Administrative support by the Royal Society of Medicine.

RESERVES POLICY

Seeks to maintain a level of reserves which provides a sustainable future for the Trust.

Page 3

THE ELLISON-CLIFFE CHARITABLE TRUST

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30[TH] SEPTEMBER 2022 (CONTINUED)

INVESTMENTS POLICY

The underlying principle is to deliver a sustainable income which also maintains, as fa as is reasonable, the capital value of the fund.

The income arising using a total return calculation is expected to be of the order of £120,000 per annum. The Investment Mangers hold a mandate which aims to return CPI = 4%. Trustees intend to invest on a responsible investment basis. In reaching this decision the Trustee gave due consideration to the judgement Butler-Sloss v The Charity Commission for England And Wales [2022] EWHC 974 (Ch), [Butler Sloss]

RISK ASSESSMENT

The trustees have reviewed the major risks to which the charity is exposed and systems have been established to mitigate those risks.

GRANTS POLICY

The Trust makes an annual award for a Travelling Fellowship. The process involves open advertisement via the Royal Society of Medicine and such other channels as the trustee’s feel is appropriate, the completion of an application form, shortlisting and interview.

FINANCIAL REVIEW

The Trustees received the majority of the legacy, amounting to £ 3m , during the financial year. This has been invested via Cazenove via a discretionary mandate. As at 30 September the investment portfolio stood at £ 2.85m . Trustees are anticipating further distribution for the Estate of Carice Ellison Cliffe in the next financial year. These are likely to be small and as yet unknown and deemed to be uncertain.

During this period the Trust paid out £45,000 in Travelling Fellowships and made a donation to the Royal Society of Medicine in respect of the Ellison-Cliffe Annual Lecture Fund of £250,000.

Page 4

THE ELLISON-CLIFFE CHARITABLE TRUST

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30[TH] SEPTEMBER 2022 (CONTINUED)

STATEMENT OF TRUSTEES’ RESPONSIBILITIES

The trustees are responsible for preparing the trustees' annual report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Charity law requires the trustees to prepare financial statements for each financial year that give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for the year. In preparing those financial statements the trustees are required to:

The trustees are responsible for keeping accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011 and regulations made thereunder. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report was agreed and signed on behalf of the Board of Trustees on 25[th] July 2023.


Dr Melita Irving (Chair)

Page 5

INDEPENDENT EXAMINER’S REPORT TO THE TRUSTEES OF THE ELLISON-CLIFFE CHARITABLE TRUST FOR THE YEAR ENDED 30 SEPTEMBER 2022

I report on the accounts of the Charity for the year ended 30 September 2022, which comprise the Statement of Financial Activities, the Balance Sheet and related notes.

This report is made to the Trustees, as a body, in accordance with the terms of my engagement. My work has been undertaken so that I might carry out an Independent Examination of the financial statements in accordance with the General Directions given by the Charity Commissioners. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Charity and the Charity’s Trustees, as a body, for my examination for this report or for the opinions I have formed.

RESPECTIVE RESPONSIBILITIES OF TRUSTEES AND EXAMINER

The Charity’s Trustees are responsible for the preparation of the financial statements: The Charity’s Trustees consider that an audit is not required for this year (under section 145 of the Charities Act 2011 (the Act) and that an independent examination is needed. It is my responsibility to examine the financial statements (under section 145(1)(a) of the Act); to follow procedures laid down in the General Directions given by the Charity Commissioners under section 145(5)(b) of the Act, and to state whether particular matters have come to my attention.

BASIS OF INDEPENDENT EXAMINER’S REPORT

My examination was carried out in accordance with the General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently no opinion is given as to whether the accounts present a “true and fair view” and the report is limited to those matters set out in the statement below.

INDEPENDENT EXAMINER’S STATEMENT

In connection with my examination, no material matters have come to my attention which gives me cause to believe that in any material respect:

I have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Kevin Lally FCA Knox Cropper LLP Chartered Accountants 65 Leadenhall Street London EC3A 2AD Date: 26th July 2023

Page 6

THE ELLISON-CLIFFE CHARITABLE TRUST

STATEMENT OF FINANCIAL ACTIVITIES

YEAR ENDED 30 SEPTEMBER 2022

Notes
INCOME FROM:
Legacies and donations
2
Investment income
Bank interest
Other income
Total
EXPENDITURE ON:
Raising funds
Charitable activities
3
Total
Net income/(expenditure) before
investment gains
Net gains/(losses) on
investments
Net income/(expenditure)
Transfers between funds
Fund balance brought
forward
NET MOVEMENT IN FUNDS
Unrestricted
Income Fund
125
60,535
128
Restricted
Travelling
Fellowship
Funds
Endowment
Funds
Total
2022
Total
2021
£
£
£
£
-
14,171
14,296
3,400,000
-
-
60,535
-
-
-
128
-
-
-
-
-
-
14,171
74,959
3,400,000
-
3,618
3,618
-
-
241,326
302,114
3,576
-
244,944
305,732
3,576
-
(230,773)
(230,773)
3,396,424
-
(218,555)
(218,555)
-
-
(449,328)
(449,328)
3,396,424
-
-
-
-
815
3,396,424
3,397,239
815
815
2,947,096
2,947,911
3,397,239
60,788
60,788
60,788
-
-
-
-
-
-

The detailed comparative Statement of Financial Activities is set out in Note 11.

Page 7

THE ELLISON-CLIFFE CHARITABLE TRUST

BALANCE SHEET

AS AT 30 SEPTEMBER 2022

Notes
FIXED ASSETS
Tangible Assets
Investments
5
CURRENT ASSETS
Bank Balances
Cash with investment managers
Debtors
6
Creditors: Amounts falling due
within one year
7
NET ASSETS
FUNDS
Endowment Funds
8
Restricted Funds:
Travelling Fellowship Fund
9
Unrestricted income fund
2022
£
£
-
2,841,054
54,973
57,045
815
112,833
(5,976)
106,857
2,947,911
2,947,096
815
-
2,947,911
2021
£
£
-
-
-
-
3,400,815
3,400,815
(3,576)
3,397,239
3,397,239
3,396,424
815
-
3,397,239
2021
£
£
-
-
-
-
3,400,815
3,400,815
(3,576)
3,397,239
3,397,239
3,396,424
815
-
3,397,239
3,397,239
3,396,424
815
-
3,397,239

The financial statements were approved by the Board of Trustees on 25[th] July 2023 and were signed on its behalf by:


Dr Melita Irving (Chair)

Page 8

THE ELLISON-CLIFFE CHARITABLE TRUST

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 30 SEPTEMBER 2022

1. ACCOUNTING POLICIES

The accounts have been prepared to give a “true and fair” view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a “true and fair view”. This departure involved following the latest Charities SORP (FRS 102) issued in 2019 rather than the superseded Charities SORP which was issued in 2005 and which is still referred to in the regulations.

The functional currency is the £ sterling.

The Ellison-Cliffe Charitable Trust meets the definition of a public benefit entity under FRS102.

The trustees consider that there are no material uncertainties about the Charity’s ability to continue as a going concern.

Donations are accounted for in the year in which they are received and legacies are accounted for when the charity become entitled to the income, when receipt is probable and the amount receivable can be reasonably estimated.

Income from investments, together with any associated tax credit, is accounted for in the year in which it is due to be received.

Grants to beneficiaries are treated as an application of income in the year in which they are approved for payment.

Administration expenses are shown inclusive of VAT, where applicable.

Investments are a form of basic financial investment and are initially recognised at their transaction value and subsequently measured at fair value as at the balance sheet date using the closing quoted market price. The statement of financial activities includes the net gains and losses arising on revaluations and disposals throughout the year.

Realised gains and losses on investments are calculated as the difference between sales proceeds and their opening carrying value or their purchase value if acquired subsequent to the first day of the financial year. Unrealised gains and losses are calculated as the difference between the fair value at the year end and their carrying value.

Page 9

THE ELLISON-CLIFFE CHARITABLE TRUST

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 30 SEPTEMBER 2021

g. Funds

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objects of the Charity and which have not been designated for other purpose.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors which have been raised by the Charity for particular purposes. The cost of administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Expendable endowment funds are held by the charity and invested to generate an investment return. However, the capital may also be spent at the discretion of the trustees.

Page 10

THE ELLISON-CLIFFE CHARITABLE TRUST

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 30 SEPTEMBER 2022

2. DONATIONS AND LEGACY

Legacy: Dr Carice Ellison-Cliffe
3.
CHARITABLE ACTIVITIES
Travelling Fellowship grants
RSM Lecture fund donation
Support Costs (Note 4)
4.SUPPORT COSTS
Audit/Independent examination Fees
Legal fees
Bank charges
2022
£
14,171
14,171
2022
£
45,000
250,000
7,114
302,114
2022
£
2,400
4,562
152
7,114
2021
£
3,400,000
3,400,000
2021
£
-
-
3,576
3,576
2021
£
3,576
-
-
3,576

5. INVESTMENTS

Market value at 1 October
Additions
Disposals
Gains/(losses) on investments
Market value at 30 September
Investment at cost at 30 September
2022
£
-
3,059,609
-
(218,555)
2,841,054
3,059,609

The charity holds 5,107,054 units in the Cazenove Charity Multi-Asset Fund.

Page 11

THE ELLISON-CLIFFE CHARITABLE TRUST

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 30 SEPTEMBER 2022

6. DEBTORS

6.DEBTORS
Debtor – Legacy Receivable
Amount due from the Royal Society of Medicine
7.CREDITORS
Accruals
8.ENDOWMENT FUNDS
Endowment funds
Balance
30/09/21
£
Expendable Endowment
3,396,424
3,396,424
Endowment funds – comparative
2021
Balance
30/09/20
£
Expendable Endowment
-
-
2022
2021
£
£
-
3,400,000
815
815
815
3,400,815
2022
2021
£
£
5,976
3,576
5,976
3,576
Gain/(Loss)
on
Investments
Net
movement in
the year
Balance
30/09/22
£
£
£
(218,555)
(230,773)
2,947,096
(218,555)
(230,773)
2,947,096
Gain/(Loss)
on
Investments
Net
movement in
the year
Balance
30/09/21
£
£
£
-
3,396,424
3,396,424
-
3,396,424
3,396,424
2,947,096
Balance
30/09/21
£
3,396,424
3,396,424

Page 12

THE ELLISON-CLIFFE CHARITABLE TRUST

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 30 SEPTEMBER 2022

9 . RESTRICTED FUNDS

Restricted Funds
Balance
30/09/21
£
Travelling Fellowship Fund
815
815
Restricted Funds –comparative
2021
Balance
30/09/20
£
Travelling Fellowship Fund
815
815
10.SPLIT OF ASSETS BETWEEN FUNDS
Unrestricted
Income Fund
Investments
-
Current Assets
-
Current Liabilities
-
-
Split of Assets Between Fund –
at 30 September 2021
Unrestricted
Income Fund
Investments
-
Current Assets
-
Current Liabilities
-
-
Net
Incoming
Resources
£
-
-
Net
Incoming
Resources
£
-
-
Restricted
Funds
£
-
815
-
815
Restricted
Funds
£
-
815
-
815
Resources
Expended
Balance
30/09/22
£
£
-
815
-
815
Resources
Expended
Balance
30/09/21
£
£
-
815
-
815
Endowments
Total
£
£
2,841,054
2,841,054
112,018
112,833
(5,976)
(5,976)

2,947,096
2,947,911
Endowments
Total
£
£
-
-
3,400,000
3,400,815
(3,576)
(3,576)
3,396,424
3,397,239
Resources
Expended
Balance
30/09/22
£
£
-
815
-
815
Resources
Expended
Balance
30/09/21
£
£
-
815
-
815
Endowments
Total
£
£
2,841,054
2,841,054
112,018
112,833
(5,976)
(5,976)

2,947,096
2,947,911
Endowments
Total
£
£
-
-
3,400,000
3,400,815
(3,576)
(3,576)
3,396,424
3,397,239
2,947,911
Total
£
-
3,400,815
(3,576)
3,397,239

Page 13

THE ELLISON-CLIFFE CHARITABLE TRUST

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 30 SEPTEMBER 2022

11. TRUSTEES REMUNERATION AND RELATED PARTY TRANSACTIONS

There were no trustees’ remuneration or other expenses for the year ended 30 September 2022 (2021: none).

Dr. Melita Irving is also a trustee of The Royal Society of Medicine. At the year end there is a balance of £815 owed by The Royal Society of Medicine.

The Royal Society of Medicine is providing agreed administrative tasks for which a fee will be charged from next year.

12. COMPARATIVE FIGURES FOR THE STATEMENT OF FINANCIAL ACTIVITIES AS REQUIRED BY FRS 102

INCOMING RESOURCES
Legacies and donations
Investment income
Bank interest
Total
EXPENDITURE ON
Raising funds
Charitable activities
Total
Net
income/(expenditure)
before
investment gains
Net gains/(losses) on investment
Net income/(expenditure)
Fund balance brought forward
NET MOVEMENT IN FUNDS
Restricted
Travelling
Funds
£
-
-
-
-
-
-
-
-
-
-
815
815
Endowment
Funds
£
3,400,000
-
-
3,400,000
-
3,576
3,576
3,396,424
-
3,396,424
-
3,396,424
Total
2021
£
3,400,000
-
-
3,400,000
-
3,576
3,576
3,396,424
-
3,396,424
815
3,397,239